About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
14.30-14.45. Welcome and introduction: Anna Millan (BST) + Carlota Villar (BCN-PIDFoundation) + Pere Soler Palacin (VH)
14.45-15.35. Is the donor a limiting factor?
Chairs: Sergi Querol (BST) + Cristina Diaz de Heredia (VH) (2 x 20 min and 10 min Q&A) • CD45RO+ infusion options: Andrew Gennery (University of Newcastle upon Tyne) • Selectively depleted transplants in Catalonia: Jesús Fernández (BST)
15.35-16.50. Immunological reconstitution after SCT
Chairs: Pere Soler (VH) (3 x 20 min and 15 min Q&A) • Monitoring options in Catalonia: Emma Enrich (BST) • Our experience: Alba Parra (VHIR) • Long-term follow-up of IEI transplanted patients. What have we learned over the last decade?: Elie Haddad (CHU Sainte-Justine)
16.50-17.10. Short break
17.10-18.00. Transplanting adults with IEI
Chairs: Laura Fox (VH)
• SCT in adults with IEI: Emma Morris (UCL Institute of Immunity & Transplantation)
•Our experience across ages: Laura Alonso (VH-paediatrics) & Laura Fox (VH-adults)
18.00-18.15. SCT in IEI. Video experience
18.15-18.30. Closing session: Pere Soler Palacin (VH) + Cristina Diaz de Heredia (VH) Organizers: BCN PID Foundation | HUVH | BST
Organizers: BCN PID Foundation | HUVH | BBST
Register here to attend by Zoom click here
Jornada 'Optimizing transplantation of congenital errors of immunity'
PDF 0.48 MB
